Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-25-010590

Chair and CEO sold 25,580 shares at an average $77.79 ($1,989,797)

  • Chair and CEO acquired 25,580 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lewis William · Chair and CEO

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-03 Exercise or conversion : show line 1 in the form 10b5-1 +18,750 $22.76 $426,750 352,936 D
2025-03-03 Sale : show line 2 in the form 10b5-1 −7,317 $76.24 $557,848 345,619 D
2025-03-03 Sale : show line 3 in the form 10b5-1 −758 $77.75 $58,935 344,861 D
2025-03-03 Sale : show line 4 in the form 10b5-1 −7,763 $78.61 $610,249 337,098 D
2025-03-03 Sale : show line 5 in the form 10b5-1 −2,785 $79.43 $221,213 334,313 D
2025-03-03 Sale : show line 6 in the form 10b5-1 −127 $80.90 $10,274 334,186 D
2025-03-03 Exercise or conversion : show line 7 in the form 10b5-1 +6,830 $10.85 $74,106 240,754 I
2025-03-03 Sale : show line 8 in the form 10b5-1 −2,671 $76.23 $203,610 238,083 I
Open-market sales · 25,580 sh · avg $77.79 · $1,989,797

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-03-03 Exercise or conversion : show line 13 in the form 10b5-1 Stock Option (right to buy) −18,750 18,750 D
2025-03-03 Exercise or conversion : show line 14 in the form 10b5-1 Stock Option (right to buy) −6,830 198,140 I
Loading xslF345X05/wk-form4_1741213663.xml…